Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?
about
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate CancerAndrogen deprivation therapy as backbone therapy in the management of prostate cancerAutophagy activated by the c-Jun N-terminal kinase-mediated pathway protects human prostate cancer PC3 cells from celecoxib-induced apoptosisRole of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.Cardiovascular toxicities of systemic treatments of prostate cancer.Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer.Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled tri(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapy.Radiotherapy for isolated lymph node metastases in patients with locally advanced prostate cancer after primary therapy.Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer
P2860
Q26744431-34CA197E-ECDF-4F59-9D19-F8A9AC4F6FFAQ28071795-EB6B03F1-FA31-456A-8244-03E58A9B83AEQ38701724-625CC02D-8557-476E-8E71-5F140E8E5D96Q38998655-0F528599-6DDD-44CE-A029-4E8A95341301Q39002111-D13FC374-0483-4558-BFA2-B964E6D2DF5CQ39003600-3FC626CA-82CF-433B-BD56-967390EC713BQ42228044-0D575968-9F45-42CE-ABC1-9CF066401798Q51715242-21963FCD-E3F2-45A6-A0AB-6DE40456401BQ53267613-F59AF5E1-DCEA-4827-8A4D-E3FF1FC96A82Q58542923-EE4C83DD-22C4-4F3D-899F-984308FE9F16
P2860
Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Androgen deprivation therapy i ...... GnRH agonist backbone therapy?
@ast
Androgen deprivation therapy i ...... GnRH agonist backbone therapy?
@en
type
label
Androgen deprivation therapy i ...... GnRH agonist backbone therapy?
@ast
Androgen deprivation therapy i ...... GnRH agonist backbone therapy?
@en
prefLabel
Androgen deprivation therapy i ...... GnRH agonist backbone therapy?
@ast
Androgen deprivation therapy i ...... GnRH agonist backbone therapy?
@en
P2093
P2860
P921
P1476
Androgen deprivation therapy i ...... GnRH agonist backbone therapy?
@en
P2093
Axel S Merseburger
Fernando Calais da Silva
Francois Rozet
Peter Hammerer
Thierry Roumeguère
P2860
P2888
P304
P356
10.1007/S00345-014-1406-2
P577
2014-09-27T00:00:00Z
2015-08-01T00:00:00Z